In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 15804-19-0, name is Quinoxaline-2,3(1H,4H)-dione, introducing its new discovery. Recommanded Product: 15804-19-0
Isolated linear CuCN chains in a 2,3-dihydroxyquinoxaline host lattice
CuCN ¡¤ 2,3-dihydroxyquinoxaline (1) can be crystallised by slowly cooling an acetonitrile solution of the components from 100 to 20C. 1 contains two polymeric isolated ?1[CuCN] chains within the open channels provided by hydrogen bonded stacks of 2,3-dihydroxyquinoxaline molecules. Positional disorder is observed for the C/N atoms of the bridging cyanide ligands within the effectively linear ?1[CuCN] chains, which exhibit angles of 169.9(2) at Cu and 171.8(6)/178.1(6) at the C/N atoms. Only very weak O . . . Cu interactions of 2.728(5) and 2.697(5) A are observed between the CuCN chains and the 2,3-dihydroxyquinoxaline stacks. Wiley-VCH Verlag GmbH, 2001.
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 15804-19-0, and how the biochemistry of the body works.Recommanded Product: 15804-19-0
Reference£º
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N330 | ChemSpider